{"title":"Investigation of Walking Ability in 161 Patients With Duchenne Muscular Dystrophy.","authors":"Ying Guo, Xiaofang Wu, Yun Xie, Wen Zhai, Na Cai, Wenhao Shi, Hua Chen, Tingting Liu, Qiaowei Shi, Xiao Ge Zhang","doi":"10.1177/00099228261429136","DOIUrl":null,"url":null,"abstract":"<p><p>We aimed to identify modifiable risk factors affecting ambulation in Chinese children with Duchenne muscular dystrophy (DMD) by analyzing follow-up data from 161 patients with DMD. Continuous variables were compared using <i>t</i>-test or the Wilcoxon rank-sum test (for non-normally distributed variables). Cox regression determined factors influencing walking ability, and the log-rank test compared retention of walking ability between school-going and non-school-going patients. Hormone therapy (HR 3.72; <i>P</i> = .033), school attendance (HR 5.20; <i>P</i> = .010), and Disability and Social Support Rating Scale scores (HR 1.16; <i>P</i> = .021) significantly predicted loss of ambulation. Vitamin D levels were lower in ambulatory children with DMD who lost the ability to walk (F = 26.246, <i>P</i> = .000). Hormone therapy improved the 10-m walking time, while rehabilitation influenced the decumbent position and walking times. Early hormone therapy combined with consistent rehabilitation and school engagement is recommended for preserving ambulation.</p>","PeriodicalId":10363,"journal":{"name":"Clinical Pediatrics","volume":" ","pages":"99228261429136"},"PeriodicalIF":0.7000,"publicationDate":"2026-03-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical Pediatrics","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1177/00099228261429136","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"PEDIATRICS","Score":null,"Total":0}
引用次数: 0
Abstract
We aimed to identify modifiable risk factors affecting ambulation in Chinese children with Duchenne muscular dystrophy (DMD) by analyzing follow-up data from 161 patients with DMD. Continuous variables were compared using t-test or the Wilcoxon rank-sum test (for non-normally distributed variables). Cox regression determined factors influencing walking ability, and the log-rank test compared retention of walking ability between school-going and non-school-going patients. Hormone therapy (HR 3.72; P = .033), school attendance (HR 5.20; P = .010), and Disability and Social Support Rating Scale scores (HR 1.16; P = .021) significantly predicted loss of ambulation. Vitamin D levels were lower in ambulatory children with DMD who lost the ability to walk (F = 26.246, P = .000). Hormone therapy improved the 10-m walking time, while rehabilitation influenced the decumbent position and walking times. Early hormone therapy combined with consistent rehabilitation and school engagement is recommended for preserving ambulation.
我们旨在通过分析161例杜氏肌营养不良症(DMD)患儿的随访数据,确定影响DMD患儿行走的可改变危险因素。使用t检验或Wilcoxon秩和检验(非正态分布变量)比较连续变量。Cox回归确定影响步行能力的因素,log-rank检验比较上学和不上学患者的步行能力保留情况。激素治疗(HR 3.72; P = 0.033)、学校出勤率(HR 5.20; P = 0.010)和残疾和社会支持评定量表评分(HR 1.16; P = 0.021)显著预测活动能力丧失。失去行走能力的DMD患儿的维生素D水平较低(F = 26.246, P = 0.000)。激素治疗提高了10米步行时间,而康复治疗影响了仰卧位和步行时间。建议早期激素治疗结合持续的康复和学校参与来保持活动。
期刊介绍:
Clinical Pediatrics (CLP) a peer-reviewed monthly journal, is a must read for the busy pediatrician. CLP contains state-of-the-art, accurate, concise and down-to earth information on practical, everyday child care topics whether they are clinical, scientific, behavioral, educational, or ethical.